BioSpace News Archive

Study indicates comparable image quality to conventional protocols at 64% of the original dose using Samsung’s GM85 Mobile System with S-Vue™ Image Engine

Actinium Pharmaceuticals, Inc. announced that its Board of Directors approved a 1-for-30 reverse split of its issued and outstanding common stock that will become effective after trading closes on August 10, 2020.

Micro-Tech Endoscopy USA recently announced an expansion of their SureClip portfolio – the Lockado Hemostasis Clip.

Company increases manufacturing capacity of U.S.-made drug to ensure uninterrupted supply for patients undergoing treatment amid industry shortage

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, announced corporate updates and financial results for the second quarter and six months ended June 30, 2020.

Harrow Health, Inc. reported results for the second quarter 2020. Please click here to review Harrow Health’s Letter to Stockholders for the second quarter 2020.

Initiation of CLS-AX Phase 1/2a Clinical Trial in Wet AMD Targeted by Year-End 2020

Clearside Biomedical, Inc., a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, reported financial results for the second quarter ended June 30, 2020 and provided a corporate update on key initiatives.

Longer treatment regimens could be required to see reduction or eradication of more resistant pulmonary strains

Integra LifeSciences Holdings Corporation, a leading global medical technology company, reported financial results for the second quarter ending June 30, 2020.